BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,346,296 | -25.6% | 62,170 | -10.2% | 0.06% | -25.6% |
Q2 2023 | $3,154,802 | +5.5% | 69,245 | -6.1% | 0.08% | -4.7% |
Q1 2023 | $2,991,097 | -66.3% | 73,745 | -57.7% | 0.09% | -33.8% |
Q4 2022 | $8,888,556 | +68.0% | 174,388 | +77.5% | 0.13% | -24.0% |
Q3 2022 | $5,290,000 | -20.1% | 98,223 | -4.7% | 0.17% | -13.6% |
Q2 2022 | $6,618,000 | -30.2% | 103,033 | -15.7% | 0.20% | -16.5% |
Q1 2022 | $9,480,000 | -24.2% | 122,263 | -16.1% | 0.24% | -20.5% |
Q4 2021 | $12,504,000 | -51.1% | 145,665 | -54.2% | 0.30% | -55.1% |
Q3 2021 | $25,590,000 | -3.5% | 318,166 | -3.4% | 0.66% | -5.8% |
Q2 2021 | $26,515,000 | +2.4% | 329,377 | +7.2% | 0.70% | -11.9% |
Q1 2021 | $25,905,000 | -6.7% | 307,152 | -11.2% | 0.80% | -13.2% |
Q4 2020 | $27,758,000 | -7.1% | 345,943 | -6.9% | 0.92% | -16.0% |
Q3 2020 | $29,867,000 | -7.4% | 371,391 | -0.9% | 1.10% | -8.5% |
Q2 2020 | $32,252,000 | +2.5% | 374,591 | -3.3% | 1.20% | -14.3% |
Q1 2020 | $31,458,000 | -18.9% | 387,455 | -16.5% | 1.40% | +9.2% |
Q4 2019 | $38,781,000 | -6.6% | 463,780 | -2.3% | 1.28% | -12.4% |
Q3 2019 | $41,517,000 | +1.2% | 474,640 | -5.2% | 1.46% | +1.5% |
Q2 2019 | $41,015,000 | -3.5% | 500,799 | -4.2% | 1.44% | -5.1% |
Q1 2019 | $42,485,000 | +18.9% | 522,510 | -3.8% | 1.52% | +5.9% |
Q4 2018 | $35,737,000 | -20.3% | 542,957 | -6.7% | 1.43% | +0.7% |
Q3 2018 | $44,848,000 | -20.1% | 581,756 | -23.5% | 1.42% | -24.5% |
Q2 2018 | $56,149,000 | +10.5% | 760,408 | -2.7% | 1.89% | +10.2% |
Q1 2018 | $50,829,000 | -3.7% | 781,500 | -4.3% | 1.71% | -1.2% |
Q4 2017 | $52,794,000 | -2.2% | 816,741 | -5.0% | 1.73% | -2.4% |
Q3 2017 | $53,968,000 | -1.7% | 860,048 | -5.1% | 1.78% | -4.0% |
Q2 2017 | $54,884,000 | +13.5% | 906,582 | -2.8% | 1.85% | +9.3% |
Q1 2017 | $48,368,000 | +12.2% | 932,666 | -4.0% | 1.69% | +9.1% |
Q4 2016 | $43,090,000 | -11.9% | 971,811 | -5.4% | 1.55% | -12.1% |
Q3 2016 | $48,895,000 | -17.9% | 1,027,204 | -22.0% | 1.76% | -16.1% |
Q2 2016 | $59,553,000 | +0.1% | 1,316,979 | -9.1% | 2.10% | +1.2% |
Q1 2016 | $59,488,000 | +2.3% | 1,448,104 | -5.0% | 2.08% | +4.8% |
Q4 2015 | $58,160,000 | -6.7% | 1,524,505 | -19.7% | 1.98% | +5.1% |
Q3 2015 | $62,345,000 | -55.0% | 1,897,896 | -4.3% | 1.89% | -47.8% |
Q2 2015 | $138,691,000 | -4.4% | 1,983,293 | -6.3% | 3.61% | -0.5% |
Q1 2015 | $145,062,000 | -9.1% | 2,117,698 | -2.8% | 3.63% | -6.3% |
Q4 2014 | $159,598,000 | -0.1% | 2,177,626 | -2.1% | 3.87% | +3.2% |
Q3 2014 | $159,690,000 | -0.2% | 2,225,027 | +0.6% | 3.75% | +4.5% |
Q2 2014 | $159,968,000 | -3.1% | 2,212,554 | -1.4% | 3.59% | -6.9% |
Q1 2014 | $165,043,000 | +5.5% | 2,243,050 | -0.3% | 3.86% | +0.9% |
Q4 2013 | $156,424,000 | +18.0% | 2,249,087 | +11.4% | 3.82% | +9.6% |
Q3 2013 | $132,567,000 | -1.8% | 2,018,068 | +3.5% | 3.49% | -5.3% |
Q2 2013 | $135,058,000 | – | 1,949,736 | – | 3.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
Third Point | 4,000,000 | $344,400,000 | 4.72% |
Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |